Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
- DOI
- 10.1186/s13063-019-3336-1
- Published
- 2019 Jun 7
- Container
- Trials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-019-3336-1,
title = {Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).},
author = {Lennox B and Yeeles K and Jones PB and Zandi M and Joyce E and Yu LM and Tomei G and Pollard R and Vincent SA and Shimazaki M and Cairns I and Dowling F and Kabir T and Barnes TRE and Lingford Hughes A and Hosseini AA and Harrower T and Buckley C and Coles A},
year = {2019},
journal = {Trials},
doi = {10.1186/s13063-019-3336-1},
url = {https://doi.org/10.1186/s13063-019-3336-1}
}RIS
TY - JOUR TI - Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2). AU - Lennox B AU - Yeeles K AU - Jones PB AU - Zandi M AU - Joyce E AU - Yu LM AU - Tomei G AU - Pollard R AU - Vincent SA AU - Shimazaki M AU - Cairns I AU - Dowling F AU - Kabir T AU - Barnes TRE AU - Lingford Hughes A AU - Hosseini AA AU - Harrower T AU - Buckley C AU - Coles A PY - 2019 JO - Trials DO - 10.1186/s13063-019-3336-1 UR - https://doi.org/10.1186/s13063-019-3336-1 ER -
APA
B, L., K, Y., PB, J., M, Z., E, J., LM, Y., G, T., R, P., SA, V., M, S., I, C., F, D., T, K., TRE, B., A, L. H., AA, H., T, H., C, B., & A, C. (2019). Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).. Trials. https://doi.org/10.1186/s13063-019-3336-1
Source records
- pubmed · retrieved 2026-09-26T22:47:58.013Z